Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.3K
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

349
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
349
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

4.8K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
4.8K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

11.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.5K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.7K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CCL20 is overexpressed in hepatocellular carcinoma with bile duct tumor thrombus and correlates negatively with surgical outcome.

International journal of clinical and experimental pathology·2020
Same author

Association between glutathione S-transferase M1 polymorphism and esophageal cancer: a pooled analysis based on Chinese individuals.

International journal of clinical and experimental pathology·2020
Same author

DNA methylation profiling in recurrent miscarriage.

PeerJ·2020
Same author

Superficial spreading squamous cell carcinoma in situ of the cervix involving the endometrium: a rare case presentation and review of literature.

International journal of clinical and experimental pathology·2020
Same author

The association of preoperative anxiety and depression with neurocognitive disorder following oncological surgery.

Journal of surgical oncology·2020
Same author

Contrasting effects of acute and long-term corticosterone treatment on amyloid-β, beta-secretase 1 expression, and nuclear factor kappa B nuclear translocation.

Journal of integrative neuroscience·2020
Same journal

Recent Advancements of Transcranial Direct Current Stimulation and Machine Learning: Methods, Challenges, and Opportunities.

Transactions on artificial intelligence·2026
Same journal

Normalization and Selecting Non-Differentially Expressed Genes Improve Machine Learning Modelling of Cross-Platform Transcriptomic Data.

Transactions on artificial intelligence·2025
See all related articles

Related Experiment Video

Updated: Jan 14, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.4K

Self-Supervised Based Multi-View Graph Presentation Learning for Drug-Drug Interaction Prediction.

Kuang Du1, Jing Du2, Zhi Wei1

  • 1Department of Computer Science, New Jersey Institute of Technology, Newark, NJ 07102, USA.

Transactions on Artificial Intelligence
|October 17, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces Self-Supervised Multi-View Graph Representation Learning (SMG-DDI) to predict drug-drug interactions (DDIs). SMG-DDI effectively uses unlabeled molecular data, outperforming current methods for DDI prediction.

Keywords:
drug-drug interactionhierarchical graph representation learningmolecular structural informationself-supervised learning

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K

Related Experiment Videos

Last Updated: Jan 14, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.4K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K

Area of Science:

  • Computational chemistry
  • Bioinformatics
  • Machine learning in drug discovery

Background:

  • Drug-drug interactions (DDIs) pose significant risks in polypharmacy, necessitating accurate prediction methods.
  • Existing hierarchical graph representation learning for DDIs faces limitations due to scarce experimental data and potential overfitting with supervised methods.
  • Supervised models fail to utilize vast unlabeled public molecular datasets, hindering performance.

Purpose of the Study:

  • To develop a novel multi-view graph representation learning method, SMG-DDI, for enhanced drug-drug interaction prediction.
  • To overcome the data scarcity bottleneck in DDI prediction by leveraging unlabeled molecular datasets.
  • To improve the accuracy and generalizability of DDI prediction models.

Main Methods:

  • Proposed Self-Supervised Multi-View Graph Representation Learning (SMG-DDI) for DDI prediction.
  • Utilized a pre-trained Graph Convolutional Network (GCN) for inter-view molecule graph representation learning (atoms as nodes, bonds as edges).
  • Captured intra-view molecular interactions and generated drug embeddings for final DDI prediction.

Main Results:

  • SMG-DDI demonstrated superior performance compared to state-of-the-art DDI prediction methods across various dataset scales.
  • Achieved prediction accuracies of 0.83, 0.79, and 0.73 on small, medium, and large test datasets, respectively.
  • Validated that molecular structure information significantly aids in predicting potential drug-drug interactions.

Conclusions:

  • SMG-DDI effectively addresses data limitations in DDI prediction by incorporating self-supervised learning and multi-view graph representations.
  • The proposed method offers a promising approach for accurate and reliable prediction of drug-drug interactions.
  • Leveraging unlabeled molecular data through advanced graph representation learning enhances DDI prediction capabilities.